Metformin is the first-line medication worldwide for the treatment of T2DM, which acts by reducing glucose production and stimulating glucose uptake in muscle cells, thus lowering circulating glucose and insulin levels [32]. This evidence concerns the gene INS and type 2 diabetes mellitus.